{"disease":{"id":"coronavirus-disease-19","name":"coronavirus disease 19"},"drugs":{"marketed":[{"drug_id":"tocilizumab","indication_name":"Coronavirus Disease 2019 (COVID-19)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07072793","title":"A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe","phase":"","overall_status":"COMPLETED","enrollment_count":131005,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04979208","title":"Impact of Changes in the Use of Care and Reorganization of the Healthcare System Linked to the Covid-19 Outbreak on the Quality of Care Pathways of Patients Suffering From Acute Myocardial Infarction and Stroke in Aquitaine (AVICOVID)","phase":"","overall_status":"COMPLETED","enrollment_count":9218,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04941144","title":"Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":8538,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT05097677","title":"Follow-up of Covid-19 Long Term Sequelae","phase":"","overall_status":"COMPLETED","enrollment_count":7599,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT04327206","title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6828,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT04375761","title":"COVID-19: Human Epidemiology and Response to SARS-CoV-2","phase":"","overall_status":"COMPLETED","enrollment_count":5599,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04545047","title":"Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":5044,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05594147","title":"An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib","phase":"","overall_status":"COMPLETED","enrollment_count":4103,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04348214","title":"Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals","phase":"","overall_status":"COMPLETED","enrollment_count":4040,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05722665","title":"Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs","phase":"","overall_status":"COMPLETED","enrollment_count":3599,"lead_sponsor_name":"Fundacion Clinica Valle del Lili","has_results":false},{"nct_id":"NCT06667700","title":"A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":3082,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06821061","title":"A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":2650,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT05534074","title":"University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"University Hospital, Ioannina","has_results":false},{"nct_id":"NCT04939428","title":"Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2441,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05330832","title":"Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)","phase":"","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","has_results":false},{"nct_id":"NCT05787431","title":"Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Emmanouil D. Zacharakis","has_results":false},{"nct_id":"NCT04443712","title":"Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)","phase":"","overall_status":"UNKNOWN","enrollment_count":1900,"lead_sponsor_name":"Samia Girgis","has_results":false},{"nct_id":"NCT04575597","title":"Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1735,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04573062","title":"Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health","phase":"","overall_status":"RECRUITING","enrollment_count":1590,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT04508023","title":"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1284,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04378777","title":"Immunophenotyping Assessment in a COVID-19 Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":1227,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05094687","title":"Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).","phase":"","overall_status":"COMPLETED","enrollment_count":1206,"lead_sponsor_name":"Jinnah Postgraduate Medical Centre","has_results":false},{"nct_id":"NCT07089680","title":"A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04760990","title":"A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.","phase":"","overall_status":"COMPLETED","enrollment_count":1181,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT06392451","title":"LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"DiaSorin Molecular LLC","has_results":false},{"nct_id":"NCT04558307","title":"Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05160636","title":"A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":999,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04944433","title":"Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":950,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT04350931","title":"Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04394117","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":787,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT05364671","title":"Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":771,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT05492227","title":"SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study","phase":"","overall_status":"COMPLETED","enrollment_count":607,"lead_sponsor_name":"TransGen Biotech Co., LTD","has_results":false},{"nct_id":"NCT04659356","title":"NOSOcomial COVID-19 in ICU (NOSOCOVID)","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT06189040","title":"Immunogenicity After COVID-19 Vaccines in Adapted Schedules","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04286503","title":"The Clinical Study of Carrimycin on Treatment Patients With COVID-19","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":520,"lead_sponsor_name":"Beijing YouAn Hospital","has_results":false},{"nct_id":"NCT05364268","title":"Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation","phase":"","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"AudibleHealth AI, Inc.","has_results":false},{"nct_id":"NCT05164744","title":"Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors","phase":"","overall_status":"RECRUITING","enrollment_count":510,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT04346056","title":"Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04347239","title":"Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":484,"lead_sponsor_name":"CytoDyn, Inc.","has_results":true},{"nct_id":"NCT04724850","title":"Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura","phase":"","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"Juan Fernando Masa Jiménez","has_results":false},{"nct_id":"NCT04497194","title":"Registry of COVID-19 Patients at AOUI Verona","phase":"","overall_status":"COMPLETED","enrollment_count":430,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT05089045","title":"Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity","phase":"NA","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT05007080","title":"A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT04575584","title":"Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":304,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04355351","title":"Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)","phase":"NA","overall_status":"COMPLETED","enrollment_count":303,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT04403932","title":"Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT05128643","title":"Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT04898166","title":"Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Syeda Mahanum Ali","has_results":true},{"nct_id":"NCT05107375","title":"Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT05184062","title":"A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"AstraZeneca","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}